(Q28272765)
Statements
Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer (English)
0 references
10 March 2010
0 references
28
0 references
8
0 references
1351-7
0 references